Literature DB >> 25444601

Does MRI scan acceleration affect power to track brain change?

Christopher R K Ching1, Xue Hua2, Derrek P Hibar2, Chadwick P Ward3, Jeffrey L Gunter3, Matt A Bernstein3, Clifford R Jack3, Michael W Weiner4, Paul M Thompson5.   

Abstract

The Alzheimer's Disease Neuroimaging Initiative recently implemented accelerated T1-weighted structural imaging to reduce scan times. Faster scans may reduce study costs and patient attrition by accommodating people who cannot tolerate long scan sessions. However, little is known about how scan acceleration affects the power to detect longitudinal brain change. Using tensor-based morphometry, no significant difference was detected in numerical summaries of atrophy rates from accelerated and nonaccelerated scans in subgroups of patients with Alzheimer's disease, early or late mild cognitive impairment, or healthy controls over a 6- and 12-month scan interval. Whole-brain voxelwise mapping analyses revealed some apparent regional differences in 6-month atrophy rates when comparing all subjects irrespective of diagnosis (n = 345). No such whole-brain difference was detected for the 12-month scan interval (n = 156). Effect sizes for structural brain changes were not detectably different in accelerated versus nonaccelerated data. Scan acceleration may influence brain measures but has minimal effects on tensor-based morphometry-derived atrophy measures, at least over the 6- and 12-month intervals examined here.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Biomarker; Drug trial enrichment; Longitudinal; MRI; Neuroimaging; Scan acceleration; Tensor-based morphometry

Mesh:

Year:  2014        PMID: 25444601      PMCID: PMC4374606          DOI: 10.1016/j.neurobiolaging.2014.05.039

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  16 in total

Review 1.  The Alzheimer's disease neuroimaging initiative: progress report and future plans.

Authors:  Michael W Weiner; Paul S Aisen; Clifford R Jack; William J Jagust; John Q Trojanowski; Leslie Shaw; Andrew J Saykin; John C Morris; Nigel Cairns; Laurel A Beckett; Arthur Toga; Robert Green; Sarah Walter; Holly Soares; Peter Snyder; Eric Siemers; William Potter; Patricia E Cole; Mark Schmidt
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

2.  MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Authors:  C R Jack; M Slomkowski; S Gracon; T M Hoover; J P Felmlee; K Stewart; Y Xu; M Shiung; P C O'Brien; R Cha; D Knopman; R C Petersen
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

Review 3.  Foundations of advanced magnetic resonance imaging.

Authors:  Roland Bammer; Stefan Skare; Rexford Newbould; Chunlei Liu; Vincent Thijs; Stefan Ropele; David B Clayton; Gunnar Krueger; Michael E Moseley; Gary H Glover
Journal:  NeuroRx       Date:  2005-04

4.  Inverse consistent mapping in 3D deformable image registration: its construction and statistical properties.

Authors:  Alex Leow; Sung-Cheng Huang; Alex Geng; James Becker; Simon Davis; Arthur Toga; Paul Thompson
Journal:  Inf Process Med Imaging       Date:  2005

5.  Statistical properties of Jacobian maps and the realization of unbiased large-deformation nonlinear image registration.

Authors:  Alex D Leow; Igor Yanovsky; Ming-Chang Chiang; Agatha D Lee; Andrea D Klunder; Allen Lu; James T Becker; Simon W Davis; Arthur W Toga; Paul M Thompson
Journal:  IEEE Trans Med Imaging       Date:  2007-06       Impact factor: 10.048

6.  Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space.

Authors:  D L Collins; P Neelin; T M Peters; A C Evans
Journal:  J Comput Assist Tomogr       Date:  1994 Mar-Apr       Impact factor: 1.826

7.  A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM).

Authors:  J Mazziotta; A Toga; A Evans; P Fox; J Lancaster; K Zilles; R Woods; T Paus; G Simpson; B Pike; C Holmes; L Collins; P Thompson; D MacDonald; M Iacoboni; T Schormann; K Amunts; N Palomero-Gallagher; S Geyer; L Parsons; K Narr; N Kabani; G Le Goualher; D Boomsma; T Cannon; R Kawashima; B Mazoyer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-08-29       Impact factor: 6.237

8.  Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition.

Authors:  Alex D Leow; Igor Yanovsky; Neelroop Parikshak; Xue Hua; Suh Lee; Arthur W Toga; Clifford R Jack; Matt A Bernstein; Paula J Britson; Jeffrey L Gunter; Chadwick P Ward; Bret Borowski; Leslie M Shaw; John Q Trojanowski; Adam S Fleisher; Danielle Harvey; John Kornak; Norbert Schuff; Gene E Alexander; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2009-04-15       Impact factor: 6.556

9.  The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI.

Authors:  P A Freeborough; N C Fox
Journal:  IEEE Trans Med Imaging       Date:  1997-10       Impact factor: 10.048

10.  3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry.

Authors:  Xue Hua; Alex D Leow; Suh Lee; Andrea D Klunder; Arthur W Toga; Natasha Lepore; Yi-Yu Chou; Caroline Brun; Ming-Chang Chiang; Marina Barysheva; Clifford R Jack; Matt A Bernstein; Paula J Britson; Chadwick P Ward; Jennifer L Whitwell; Bret Borowski; Adam S Fleisher; Nick C Fox; Richard G Boyes; Josephine Barnes; Danielle Harvey; John Kornak; Norbert Schuff; Lauren Boreta; Gene E Alexander; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2008-02-21       Impact factor: 6.556

View more
  6 in total

Review 1.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

2.  Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease.

Authors:  Prashanthi Vemuri; Matthew L Senjem; Jeffrey L Gunter; Emily S Lundt; Nirubol Tosakulwong; Stephen D Weigand; Bret J Borowski; Matt A Bernstein; Samantha M Zuk; Val J Lowe; David S Knopman; Ronald C Petersen; Nick C Fox; Paul M Thompson; Michael W Weiner; Clifford R Jack
Journal:  Neuroimage       Date:  2015-03-20       Impact factor: 6.556

3.  Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.

Authors:  Clifford R Jack; Josephine Barnes; Matt A Bernstein; Bret J Borowski; James Brewer; Shona Clegg; Anders M Dale; Owen Carmichael; Christopher Ching; Charles DeCarli; Rahul S Desikan; Christine Fennema-Notestine; Anders M Fjell; Evan Fletcher; Nick C Fox; Jeff Gunter; Boris A Gutman; Dominic Holland; Xue Hua; Philip Insel; Kejal Kantarci; Ron J Killiany; Gunnar Krueger; Kelvin K Leung; Scott Mackin; Pauline Maillard; Ian B Malone; Niklas Mattsson; Linda McEvoy; Marc Modat; Susanne Mueller; Rachel Nosheny; Sebastien Ourselin; Norbert Schuff; Matthew L Senjem; Alix Simonson; Paul M Thompson; Dan Rettmann; Prashanthi Vemuri; Kristine Walhovd; Yansong Zhao; Samantha Zuk; Michael Weiner
Journal:  Alzheimers Dement       Date:  2015-07       Impact factor: 21.566

4.  Effects of changing from non-accelerated to accelerated MRI for follow-up in brain atrophy measurement.

Authors:  Kelvin K Leung; Ian M Malone; Sebastien Ourselin; Jeffrey L Gunter; Matt A Bernstein; Paul M Thompson; Clifford R Jack; Michael W Weiner; Nick C Fox
Journal:  Neuroimage       Date:  2014-12-04       Impact factor: 6.556

5.  A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset.

Authors:  Emily N Manning; Kelvin K Leung; Jennifer M Nicholas; Ian B Malone; M Jorge Cardoso; Jonathan M Schott; Nick C Fox; Josephine Barnes
Journal:  Neuroinformatics       Date:  2017-04

6.  MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials.

Authors:  Xue Hua; Christopher R K Ching; Adam Mezher; Boris A Gutman; Derrek P Hibar; Priya Bhatt; Alex D Leow; Clifford R Jack; Matt A Bernstein; Michael W Weiner; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.